Skip to content

Insider · CIK 0001839111

Jason Alger

cfoofficer

Files at HCAT (Health Catalyst, Inc.). First filing Dec 10, 2024, latest Dec 10, 2024.

Jason Alger files SEC Form 4 as CFO at HCAT (Health Catalyst, Inc.). Since Dec 10, 2024, Jason Alger has reported 0 open-market buys worth $0 and 1 open-market sell worth $163k, the latest filed on Dec 10, 2024.

A track record needs three past buys with six months of prices behind them; Jason Alger has 0, so none is measured yet.

The newest scored trade: sold $163k of HCAT on Dec 6, 2024, filed Dec 10, 2024, scored 33 (weak), under a 10b5-1 plan.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $163k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

HCAT: Health Catalyst, Inc.

HCATOct 9, 2026 · close 1.77

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
33Weak
HCATsell 510b5-1
Health Catalyst, Inc.
$163k
19,599 shares
-18%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Sep 2, 2025 HCAT
Health Catalyst, Inc.
2,613
0.00% of outstanding
$8,787Sep 2, 2025$9,858
Jun 2, 2025 HCAT
Health Catalyst, Inc.
2,712
0.00% of outstanding
$9,858Jun 2, 2025$33k
Mar 3, 2025 HCAT
Health Catalyst, Inc.
7,304
0.01% of outstanding
$33kMar 3, 2025$233k
Dec 6, 2024 HCAT
HEALTH CATALYST INC
19,599
0.03% of outstanding
$162kDec 6, 2024$70k
Dec 2, 2024 HCAT
Health Catalyst, Inc.
7,795
0.01% of outstanding
$70kDec 2, 2024$30k

Transactions

Every row this insider has filed, 14 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 1, 2026HCAT
Health Catalyst, Inc.
FTax withholding
Common Stock
-17,973$1.70$31k704,86740 d ago
Jun 1, 2026HCAT
Health Catalyst, Inc.
FTax withholding
Common Stock
-18,804$1.37$26k722,840Jun 3, 2026
Mar 2, 2026HCAT
Health Catalyst, Inc.
FTax withholding
Common Stock
-26,970$1.66$45k741,644Mar 5, 2026
Feb 25, 2026HCAT
Health Catalyst, Inc.
AGrant or award
Common Stock
+507,500$0.00$0753,914Feb 27, 2026
Feb 25, 2026HCAT
Health Catalyst, Inc.
AGrant or award
Common Stock
+22,222$0.00$0776,136Feb 27, 2026
Feb 26, 2026HCAT
Health Catalyst, Inc.
FTax withholding
Common Stock
-7,522$1.75$13k768,614Feb 27, 2026
Dec 1, 2025HCAT
Health Catalyst, Inc.
FTax withholding
Common Stock
-20,619$2.90$60k246,414Dec 3, 2025
Sep 2, 2025HCAT
Health Catalyst, Inc.
FTax withholding
Common Stock
-2,613$3.36$8,787267,033Sep 4, 2025
Jun 2, 2025HCAT
Health Catalyst, Inc.
FTax withholding
Common Stock
-2,712$3.63$9,858269,646Jun 3, 2025
Mar 3, 2025HCAT
Health Catalyst, Inc.
FTax withholding
Common Stock
-7,304$4.58$33k272,358Mar 4, 2025
Feb 20, 2025HCAT
Health Catalyst, Inc.
AGrant or award
Common Stock
+181,000$0.00$0267,712Feb 24, 2025
Feb 20, 2025HCAT
Health Catalyst, Inc.
AGrant or award
Common Stock
+11,950$0.00$0279,662Feb 24, 2025
Dec 6, 2024HCAT
Health Catalyst, Inc.
SOpen-market sale
Common Stock10b5-1
-19,599$8.32$163k86,712Dec 10, 2024
Dec 1, 2024HCAT
Health Catalyst, Inc.
FTax withholding
Common Stock
-7,795$8.97$70k106,311Dec 3, 2024

Questions about Jason Alger

Answered from the filings on this page, as of the latest one.

Is Jason Alger buying or selling?

Not in the last 12 months. Jason Alger's latest open-market trade on SEC Form 4 was sold $163k of HCAT on Dec 6, 2024.

How did Jason Alger's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jason Alger has 0.

Where does Jason Alger file Form 4?

Jason Alger has filed Form 4 at HCAT (Health Catalyst, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jason Alger: insider trades and track record | InsiderTell